Aton Pharma CEO Mike Wells Named Ernst & Young Entrepreneur Of The Year(R) 2009 Awa... ( Award Recognizes Entrepreneurial Exce...)

Aton Pharma CEO Mike Wells Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner;

Date:6/30/2009

Award Recognizes Entrepreneurial Excellence

LAWRENCEVILLE, N.J., June 30 /PRNewswire/ -- Aton Pharma, Inc. announced today that its Chief Executive Officer, Michael G. Wells, has received the Ernst & Young Entrepreneur Of The Year(R) 2009 Award in the emerging companies category in New Jersey. According to Ernst & Young LLP, the award recognizes outstanding entrepreneurs who are building and leading dynamic, growing businesses. Mr. Wells was selected by an independent panel of judges, and the award was presented at a gala event at the Teaneck Marriott at Glenpointe on Tuesday, June 23rd, 2009.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090701/SF40163)

"I'm proud that our hard work at Aton Pharma has been publicly recognized and that we are able to make a contribution to our region's economy," said Wells. "We are continuing our commitment to expanding access to our portfolio of medically essential therapeutics in ophthalmology, acute care and orphan diseases. We take great pride in helping the patients who use our products enjoy improved outcomes and a better quality of life."

The Ernst & Young Entrepreneur Of The Year awards celebrate their 23rd anniversary this year. The program honors entrepreneurs who have demonstrated exceptionality in such areas as innovation, financial performance and personal commitment to their businesses and communities.

Aton Pharma's products include Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert), a preservative-free, once-daily*, sustained release prescription insert indicated for moderate to severe dry eye. Aton recently acquired the U.S. marketing rights to the TIMOPTIC(R) product line from Merck & Co., Inc., including TIMOPTIC in OCUDOSE(R), the only preservative-free medication for glaucoma available in the U.S.

0

GOOD

Page: 1 2 3
Related medicine news :

1. CVS/pharmacy and MinuteClinic Receive Award of Excellence from National Influenza Vaccine Summit
2. Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
3. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases
4. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
5. Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program
6. Lotus Pharmaceuticals, Inc. Again Awarded GSP Certification
7. Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Greece by SpePharm
8. Alpharmas Reach Teach Learn Initiative Targets Youth and Consumer Awareness
9. The National Council on Aging and CVS/pharmacy Educate Pennsylvania Seniors on Medication Management and How to Save Money on Prescription Drugs
10. Wolters Kluwer Healths New Forecasting Service Models Pharmas Future
11. AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium

Post Your Comments:

Aton Pharma CEO Mike Wells Named Ernst & Young Entrepreneur Of The Year(R) 2009 Awa...( Award Recognizes Entrepreneurial Exce...),Health